XTL Biopharmaceuticals Ltd.
XTLB | NASDAQ
$2.25
-$0.13 (-5.46%)
Sep 22, 2026, 10:15 AM ET · Market open
Fiscal Quarter Period Ending | Q4 2025 Dec 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 | Q4 2020 Dec 30, 2020 | Q3 2020 Sep 29, 2020 | Q2 2020 Jun 29, 2020 | Q1 2020 Mar 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PE Ratio | n/a | -2.82 | -3.16 | -4.15 | -10.75 | -0.77 | -0.53 | -0.47 | -0.64 | -1.21 | 0.96 | 1.12 | 2.58 | 2.89 | -3.04 | -2.70 | -2.13 | -1.58 | -0.95 | -0.64 | -0.29 |
PEG Ratio | n/a | 0.05 | 0.14 | 0.02 | 0.04 | -0.03 | 0.01 | 0.01 | -0.03 | 0.18 | 0 | -0.01 | -0.03 | -0.01 | 0.08 | 0.01 | 0.01 | -0.02 | 0.02 | 0 | 0 |
PS Ratio | n/a | 7.57 | 20.18 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | n/a | 0.63 | 0.57 | 1.32 | 1.52 | 0.62 | 0.49 | 0.50 | 0.58 | 0.41 | 0.32 | 0.37 | 0.55 | 0.71 | 1.88 | 1.60 | 1.01 | 0.62 | 0.41 | 0.31 | 0.22 |
P/FCF Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
P/OCF Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | -1.06 | 0.03 | 0.03 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Quick Ratio | 0.40 | 0.61 | 0.81 | 12.23 | 11.43 | 9.93 | 14.09 | 15.34 | 12.21 | 20.35 | 29.52 | 31.26 | 24 | 27 | 34.99 | 25.47 | 27.61 | 24.10 | 32.02 | 33.03 | 28.23 |
Current Ratio | 0.40 | 0.61 | 0.81 | 12.23 | 11.43 | 9.93 | 14.09 | 15.34 | 12.21 | 20.35 | 29.52 | 31.26 | 24 | 27 | 34.99 | 25.47 | 27.61 | 24.10 | 32.02 | 33.03 | 28.23 |
Asset Turnover | n/a | 0.03 | 0.02 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | 22.56 | -8.22 | -32.38 | -10.94 | n/a | -5.39 | -5.09 | -10.04 | n/a | n/a | -18.36 | -27.67 | -71.50 | -73.67 | -38.21 | -33.14 | n/a | n/a | -52.67 | n/a |
Return on Equity | n/a | -4.69% | -9.67% | -31.53% | 17.93% | -12.79% | -8.60% | -13.39% | -29.83% | -18.70% | -17.31% | -5.12% | 8.66% | 39.28% | -16.56% | -26.36% | 6.55% | 3.28% | -9.79% | -14.13% | 0.38% |
Return on Assets | n/a | -2.98% | -5.96% | -29.36% | 16.56% | -11.71% | -8.07% | -12.63% | -27.66% | -17.87% | -16.77% | -4.95% | 7.64% | 31.66% | -7.44% | -12.44% | 3.91% | 3.15% | -9.50% | -13.73% | 0.37% |
Return on Invested Capital | n/a | -8.30% | -10.94% | -18.85% | -6.47% | -9.01% | -6.04% | -6% | -8.15% | -5.63% | -4.30% | -3.62% | -3.91% | -4.48% | -6.63% | -7.99% | -3.29% | -4.11% | -3.60% | -7.19% | -3.66% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | -14.88% | 100% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | -88.24% | -341.36% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | -133.22% | -341.36% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | -280.97% | -471.60% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | -148.53% | -96.30% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove XTLB